Flerie
27.20 SEK
+2.64 %
Less than 1K followers
FLERIE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Flerie
| Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | Q1/26 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.1 | |||||||
| EBITDA | -82.2 | -274.2 | -181.0 | 167.2 | -146.7 | -538.8 | -699.5 | -62.9 |
| EBIT | -82.5 | -275.0 | -181.2 | 167.0 | -146.9 | -539.0 | -700.1 | -63.0 |
| EBIT-% | -275,000.0 % | |||||||
| Profit before taxes | -60.0 | -227.9 | -257.5 | 174.2 | -135.9 | -538.7 | -757.9 | -61.5 |
| Net income | -64.0 | -228.0 | -251.0 | 173.5 | -138.5 | -540.9 | -756.9 | -61.5 |